Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Diana Isaacs"'
Publikováno v:
Endocrine Connections, Vol 12, Iss 11, Pp 1-11 (2023)
Insulin administration remains vital to the treatment of diabetes and although there have been advances in insulin delivery, evidence suggests that many people with diabetes on insulin therapy have suboptimal glycemic management. Recent advancements
Externí odkaz:
https://doaj.org/article/8e1d00a4ee664f3d9f04dbbac73a920c
Autor:
Qinglan Ding, Erica S. Spatz, James F. Bena, Shannon L. Morrison, Michelle Levay, Haiqun Lin, Margaret Grey, Nancy E. Edwards, Diana Isaacs, Lucianne West, Pamela Combs, Nancy M. Albert
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 17 (2023)
Background It is unknown if initiation of a sodium‐glucose cotransporter‐2 inhibitor (SGLT‐2i) is associated with changes in patient‐reported health status outside of clinical trials. Methods and Results Using a prospective observational stud
Externí odkaz:
https://doaj.org/article/45c06a17ffbc447ba6d0be556d6f2147
Publikováno v:
INNOVATIONS in Pharmacy, Vol 14, Iss 2 (2023)
Sodium glucose cotransporter 2 (SGLT-2) inhibitors have demonstrated benefit in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), including slowing the progression of CKD and lowering the risk of kidney failure and death.
Externí odkaz:
https://doaj.org/article/fa500feef94748cfa1642bd2e8a7dd3c
Publikováno v:
Drugs in Context, Vol 11, Pp 1-13 (2022)
Diabetic peripheral neuropathy (DPN) is a major complication of diabetes mellitus. Tight glycaemic management focused on lowering haemoglobin A1C and increasing time in the target glucose range along with metabolic risk factor management form the cor
Externí odkaz:
https://doaj.org/article/49a807b8be52438998f2e5f91370af77
Publikováno v:
Frontiers in Nutrition, Vol 8 (2021)
Healthcare professionals in the primary care setting need to be competent to safely adapt diabetes medications when patients with Type 2 Diabetes (T2D) alter their diet. Safe prescribing practice is supported through an understanding of the clinical
Externí odkaz:
https://doaj.org/article/4454d772643b4f44b8195a56d4811157
Autor:
Lalita Prasad-Reddy, Diana Isaacs
Publikováno v:
Drugs in Context, Pp 1-19 (2015)
The prevalence of type 2 diabetes is increasing at an astounding rate. Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain. Glucagon-like peptide-1 (GLP-1) receptor agonists represent a un
Externí odkaz:
https://doaj.org/article/b4e037a5c46144d4ba855164b4367afc
Publikováno v:
Clinical Diabetes. 41:198-207
Advances in insulin delivery technologies have led to the development of tubeless “patch” systems; however, these devices still involve a level of complexity. We surveyed individuals with type 1 or type 2 diabetes to explore their attitudes and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7a706cf50f98e1b2b5fc5a38bc39850
https://doi.org/10.2337/cd22-0034
https://doi.org/10.2337/cd22-0034
Autor:
Dave L. Dixon, Ila M. Harris, Raniah Aljadeed, Keri C. Anderson, Anna Aycock, Craig Beavers, Elizabeth J. Beckman, Diana Isaacs, Emily McCoy, Anna Sandler, Joseph J. Saseen, Shivali Singh, Jamie Wagner
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 6:73-84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81b61d9fc3c111a88094e655c4ffbd18
https://doi.org/10.1002/jac5.1743
https://doi.org/10.1002/jac5.1743
Autor:
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Deborah Young-Hyman, Robert A. Gabbay
Publikováno v:
Diabetes Care
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa76f6cc822b28124f9bc30124c5aaf
https://doi.org/10.2337/dc23-s005
https://doi.org/10.2337/dc23-s005
Autor:
Nuha A. ElSayed, Grazia Aleppo, Vanita R. Aroda, Raveendhara R. Bannuru, Florence M. Brown, Dennis Bruemmer, Billy S. Collins, Marisa E. Hilliard, Diana Isaacs, Eric L. Johnson, Scott Kahan, Kamlesh Khunti, Jose Leon, Sarah K. Lyons, Mary Lou Perry, Priya Prahalad, Richard E. Pratley, Jane Jeffrie Seley, Robert C. Stanton, Robert A. Gabbay
Publikováno v:
Diabetes Care
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f010a251b4d2049fe673c49b04a1114
https://doi.org/10.2337/dc23-s016
https://doi.org/10.2337/dc23-s016